Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer A Phase 2 Clinical Trial
Author(s):
Massarelli, E.; William, W.; Johnson, F.; Kies, M.; Ferrarotto, R.; Guo, M.; Feng, L.; Lee, J.J.; Tran, H.; Kim, Y.U.; Haymaker, C.; Bernatchez, C.; Curran, M.; Barrese, T.Z.; Canales, J.R.; Wistuba, I.; Li, L.R.; Wang, J.; Burg, S.H. van der (0000-0002-6556-0354); Melief, C.J.; Glisson, B.
